LYON JOSEPH DOUGLAS (Chief Accounting Officer) received a stock award from CORCEPT THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 3/4/2026ACC: 0001193125-26-092166
Officer· Chief Accounting Officer
Since Jul 2020
+707.00
Net shares
Net buyer
$3.2K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
796.00 acquired · 89.00 disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+398.00
Price / share
$35.97
Trade value
$14.32K
% of position
3.8%
3/2/2026
10.52K→10.92K
Common Stock
Direct
Shares
+398.00
Price / share
—
Trade value
—
% of position
3.6%
3/2/2026
10.92K→11.32K
Common Stock
Direct
Shares
−89.00
Price / share
$35.97
Trade value
$3.20K
% of position
0.8%
3/3/2026
11.32K→11.23K
Total
Net shares
+707.00
Net value
$11.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | A · Award | +398.00 | $35.97 | $14.32K | 3.8% | 10.52K | 10.92K |
| Common Stock Direct | 3/2/2026 | A · Award | +398.00 | — | — | 3.6% | 10.92K | 11.32K |
| Common Stock Direct | 3/3/2026 | F · Tax Withholding | −89.00 | $35.97 | $3.20K | 0.8% | 11.32K | 11.23K |
| Total | +707.00 | $11.11K | ||||||
Derivative Transactions0
No derivative transactions reported